39. | Share-based payments |
(a) | Stock options granted as of December 31, 2017 are as follows: |
4th grant(*1) | 5th grant(*1) | 6th grant(*1) | 7th grant(*1)(*2) | |||||||||||||
Grant date |
March 30, 2005 | March 21, 2006 | March 20, 2007 | March 19, 2008 | ||||||||||||
Exercise price in won |
||||||||||||||||
Number of shares granted |
2,695,200 | 3,296,200 | 1,301,050 | 808,700 | ||||||||||||
Options expiry dates |
August 30, 2018 | August 21, 2019 | August 19, 2020 |
|
May 17, 2021/ September 17, |
| ||||||||||
Changes in number of shares granted: |
|
|||||||||||||||
Balance at January 1, 2017 |
102,389 | 108,356 | 58,764 | 45,628 | ||||||||||||
Exercised |
(99,889 | ) | (105,856 | ) | — | — | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Balance at December 31, 2017 |
2,500 | 2,500 | 58,764 | 45,628 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
|
(Expiration of |
| ||||||||||||||
Fair value per share in won |
|
21,394 |
|
|
10,571 |
|
|
3,154 |
|
|
(Expiration of |
|
(*1) | The equity instruments granted are fully vested as of December 31, 2017. The weighted average exercise price in won for 109,392 stock options outstanding at December 31, 2017 is |
(*2) | As of December 31, 2017, the exercise of the remaining for 9,466 stock options (7th grant) was temporarily suspended. |
(b) | Performance shares granted as of December 31, 2017 are as follows: |
Expired | Not expired | |||||||
Type |
Cash-settled share-based payment | |||||||
Performance conditions |
|
Increase rate of the stock price and achievement of target ROE |
| |||||
Operating period(*) |
4 or 5 years | |||||||
Estimated number of shares vested at December 31, 2017 |
273,541 | 1,165,525 | ||||||
Fair value per share in won |
|
|
(*) | Four-year period is applied from the beginning of the year that the grant date belongs while five-year period for the shares with deferred payment. |
The amount of cash payment for the Group’s cash-settled share-based payment arrangements with performance conditions is determined at the fourth anniversary date from the grant date based on the share price which is an arithmetic mean of weighted average share prices of the past two-months, past one-month and past one-week. Share price to be paid in the future is evaluated using the share price as of the end of the reporting period. For share-based payment transactions among the Group, Shinhan Financial Group receiving the services shall measure the services received as a cash-settled and the subsidiaries measure as an equity-settled share-based payment transaction, respectively.
(c) | Share-based compensation costs for the years ended December 31, 2015, 2016 and 2017 are as follows: |
2015 | ||||||||||||
Employees of | ||||||||||||
The controlling company |
The subsidiaries | Total | ||||||||||
Stock options granted : |
||||||||||||
4th |
(44 | ) | (458 | ) | (502 | ) | ||||||
5th |
(31 | ) | (500 | ) | (531 | ) | ||||||
6th |
— | — | — | |||||||||
7th |
(4 | ) | (15 | ) | (19 | ) | ||||||
Performance shares |
1,599 | 13,878 | 15,477 | |||||||||
|
|
|
|
|
|
|||||||
1,520 | 12,905 | 14,425 | ||||||||||
|
|
|
|
|
|
2016 | ||||||||||||
Employees of | ||||||||||||
The controlling company |
The subsidiaries | Total | ||||||||||
Stock options granted: |
||||||||||||
4th |
51 | 533 | 584 | |||||||||
5th |
36 | 582 | 618 | |||||||||
6th |
— | — | — | |||||||||
7th |
— | — | — | |||||||||
Performance shares |
2,890 | 23,845 | 26,735 | |||||||||
|
|
|
|
|
|
|||||||
2,977 | 24,960 | 27,937 | ||||||||||
|
|
|
|
|
|
2017 | ||||||||||||
Employees of | ||||||||||||
The controlling company |
The subsidiaries | Total | ||||||||||
Stock options granted: |
||||||||||||
4th |
67 | 413 | 480 | |||||||||
5th |
48 | 757 | 805 | |||||||||
6th |
26 | 159 | 185 | |||||||||
7th |
83 | 120 | 203 | |||||||||
Performance shares |
1,782 | 15,717 | 17,499 | |||||||||
|
|
|
|
|
|
|||||||
2,006 | 17,166 | 19,172 | ||||||||||
|
|
|
|
|
|
(d) | Accrued expenses and the intrinsic value as of December 31, 2016 and 2017 are as follows: |
2016 | ||||||||||||
Employees of | ||||||||||||
The controlling company |
The subsidiaries | Total | ||||||||||
Stock options granted: |
||||||||||||
4th |
155 | 1,611 | 1,766 | |||||||||
5th |
41 | 655 | 696 | |||||||||
6th |
— | — | — | |||||||||
7th |
— | — | — | |||||||||
Performance shares |
7,433 | 57,638 | 65,071 | |||||||||
|
|
|
|
|
|
|||||||
7,629 | 59,904 | 67,533 | ||||||||||
|
|
|
|
|
|
The intrinsic value of share-based payments is W67,533 million as of December 31, 2016. For calculating, the quoted market price W45,250 per share was used for stock options and the fair value was considered as intrinsic value for performance shares, respectively.
2017 | ||||||||||||
Employees of | ||||||||||||
The controlling company |
The subsidiaries | Total | ||||||||||
Stock options granted: |
||||||||||||
4th |
— | 54 | 54 | |||||||||
5th |
— | 26 | 26 | |||||||||
6th |
26 | 159 | 185 | |||||||||
7th |
83 | 120 | 203 | |||||||||
Performance shares |
8,286 | 62,769 | 71,055 | |||||||||
|
|
|
|
|
|
|||||||
8,395 | 63,128 | 71,523 | ||||||||||
|
|
|
|
|
|
The intrinsic value of share-based payments is W71,151 million as of December 31, 2017. For calculating, the quoted market price W49,400 per share was used for stock options and the fair value was considered as intrinsic value for performance shares, respectively.